Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07595302 · ClinicalTrials.gov registry record · Phase 4
Comparing Pain Improvement for Intravenous Versus Oral Acetaminophen in Acute Pelvic Pain
A Phase 4 study, sponsored by Montefiore Medical Center.
- Not yet
- Registry status
- Phase 4
- Development phase
- 140
- Enrollment target
NCT07595302 is a Phase 4 study that has not yet begun recruiting, run by Montefiore Medical Center. The registered enrollment target is 140 participants.
The verdict
NCT07595302, a Phase 4 study, has not yet begun recruiting, sponsored by Montefiore Medical Center.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 140 participants
- Enrollment target
Study Summary
The investigator team proposes a randomized, double-blind, double-dummy comparative effectiveness trial conducted in two urban emergency departments (EDs) in the Bronx, New York. This study is designed to determine the relative efficacy of IV acetaminophen compared to PO acetaminophen in treating pelvic pain. This design focuses on the early onset of action and short-term efficacy, which may better capture potential differences between IV and PO acetaminophen in the acute ED setting.
Interventions
- OTHER IV Placebo
- DRUG Acetaminophen 1000mg PO
- DRUG IV Acetaminophen 1000mg
- OTHER PO Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2026-07-30 |
| Est. Completion | 2027-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07595302
The ClinicalTrials.gov registry entry for NCT07595302 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which IV Placebo is the first listed.
NCT07595302 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07595302 about?
NCT07595302 is a clinical study titled "Comparing Pain Improvement for Intravenous Versus Oral Acetaminophen in Acute Pelvic Pain". The investigator team proposes a randomized, double-blind, double-dummy comparative effectiveness trial conducted in two urban emergency departments (EDs) in the Bronx, New York. This study is designed to determine the relative efficacy of IV acetaminophen compared to PO acetaminophen in treating pe...
What is the current status of trial NCT07595302?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 140 participants. The study started on 2026-07-30. Estimated completion is 2027-06-30.
What interventions are being tested in trial NCT07595302?
The interventions under investigation include: IV Placebo (OTHER), Acetaminophen 1000mg PO (DRUG), IV Acetaminophen 1000mg (DRUG), PO Placebo (OTHER).
Who is sponsoring clinical trial NCT07595302?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.